Diabetes Series 01: How Diabetes Breaks Your Body's Energy? Vital Life Choice

diseases for prevention and control:

• Type 2 Diabetes Mellitus (T2DM)
• Cardiovascular Disease (CVD)
• Neurocognitive Disorders (memory impairment, cognitive decline)
• Diabetic Complications (nephropathy, retinopathy, neuropathy)

This resource is NOT 'promoting general health' material.

References

1. World Health Organization (2015). Guideline: Sugars intake for adults and children. Geneva: WHO.
2. Attuquayefio T, et al. (2017). A four-day Western-style dietary intervention causes reductions in hippocampal-dependent learning and memory. PLoS One, 12(2):e0172645.
3. Murray S, Chen EY (2019). Examining adolescent vulnerability to obesity and diet-induced cognitive impairment. Frontiers in Neuroscience, 13:854.
4. Yang Q, et al. (2014). Added sugar intake and cardiovascular diseases mortality. JAMA Internal Medicine, 174(4):516-524.
5. Galaviz KI, et al. (2022). Interventions for reversing prediabetes: A systematic review and meta-analysis. American Journal of Preventive Medicine, 62(4):614-625.
6. Dagogo-Jack S, et al. (2022). The PROP-ABC Study: Pathobiology and reversibility of prediabetes. BMJ Open Diabetes Research & Care, 10:e002904.
7. Taylor R, et al. (2018). Primary care-led weight management for remission of type 2 diabetes (DiRECT). The Lancet, 391(10120):541-551.
8. Lean MEJ, et al. (2024). DiRECT 5-year follow-up: Durability of type 2 diabetes remission. Lancet Diabetes & Endocrinology, 12:233-246.
9. American Diabetes Association (2024). Standards of Care in Diabetes. Diabetes Care, 47(Suppl 1).
10. Emerging Risk Factors Collaboration (2023). Life expectancy associated with different ages at diagnosis of type 2 diabetes. Lancet Diabetes & Endocrinology, 11:731-742.
11. International Diabetes Federation (2021). IDF Diabetes Atlas, 10th edition. Brussels: IDF.
12. Liu J, et al. (2024). The burden of diabetes: Epidemiology, pathophysiology, and management strategies. Signal Transduction and Targeted Therapy, 9:36.

Important Statements

Upstream Disease Prevention Statement

This educational resource focuses on upstream disease prevention—preventing specific diseases before they occur through evidence-based interventions targeting identified causative agents—rather than promoting general health. VitaChoice disseminates medical research to promote the prevention and control of: Type 2 Diabetes Mellitus, Cardiovascular Disease, Neurocognitive Disorders, and Diabetic Complications.

Disclaimer

This document is for educational purposes only and does not constitute medical advice. Individual medical decisions should be made in consultation with qualified healthcare professionals. The information presented is based on peer-reviewed scientific research and international guidelines current at the time of publication.

Open Resource Sharing Statement

Open Resource — Redistribution Welcome: This educational resource may be freely shared and redistributed for non-commercial disease prevention purposes.

Please attribute to: Vital Life Choice LTD ABN: 20 695 710 082.

———————————————

Vital Life Choice LTD

ABN: 20 695 710 082 | Adelaide, South Australia

Charity, not for profit. Science over suffering. Wisdom for wellbeing.